Tokyo Elementary School Uses Animal Crossing: New Horizons for Special SDG-focused Open Class
The Floating City, a virtual island created within the popular Nintendo Switch game Animal Crossing: New Horizons (ACNH), is providing elementary schools with a platform for special lessons on the theme of SDGs. Led by the 6th Sunamachi Elementary School in Koto-ku, Tokyo, the initiative kicked off on December 10 with a special open class titled “Special Lessons in ACNH.” Participating children visited The Floating City for an opportunity to learn about environmental issues via the game.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005513/en/
The special lesson uses ACNH to transport children from their real-world school to a virtual classroom within The Floating City. (Graphic: Business Wire)
The Floating City is a virtual floating island launched within ACNH on December 8, 2020, with supervision from one co-founder of Blue Frontiers, a sustainable property developer currently working toward the creation of a real-world sustainable floating island in the Southern Hemisphere. The in-game island’s content is designed to boost interest in environmental issues among the younger generation, leveraging gameplay to encourage them to think about the future.
Special Lessons in ACNH at Koto-ku 6th Sunamachi Elementary School, Grade 5
The special open class saw participation from 30 children at Tokyo’s 6th Sunamachi Elementary School. The Floating City within ACNH is home to numerous animals, including some endangered species, and the virtual island also incorporates various activities for fun, guided learning.
Children actively asked questions in the session, which focused on current global environmental issues and was led by fisheries scientist Dr. Hiroaki Chiba, an associate professor at Kitasato University. After the lesson, Dr. Chiba commented, “Learning about the environment through games is a great educational tool which creates an opportunity to think about environmental issues and the future.”
The Floating City lets children experience environmental issues through ACNH
In the special lesson, children experienced The Floating City within ACNH through gameplay, deepening their understanding of environmental issues while visiting the island’s various virtual facilities. They learned about sustainable living on The Floating City, which echoes a real floating island, with a wind farm to create electricity through the power of nature and a restaurant serving dishes prepared only from ingredients grown on the island. The game also provides enjoyable opportunities to experience environmental issues, such as visiting a museum of endangered animals and talking with an African elephant. Children were excited by the fishing and bug-catching activities, and enthralled by the island’s many unique features.
Lesson topics: Global environmental issues and the future of fish
Dr. Hiroaki Chiba joined as a special guest instructor and delivered a lesson on what can be done to resolve current environmental issues and marine pollution. Beginning with an explanation of the serious environmental impacts of rising carbon dioxide levels, he described how Japan’s abundant ocean ecosystem has been disrupted by global warming and the acidification of seawater caused by this greenhouse gas, as well as by overfishing.
Dr. Chiba also raised the pressing issue of ocean plastic pollution, pointing out that the cumulative amount of plastic waste in the world is predicted to exceed 12 billion tons by 2050. These plastics are the source of countless “microplastic” particles that cannot be broken down by waves or ultraviolet rays, and even hold the potential to turn oceans into a plastic “soup” uninhabitable to fish. When asked by the children about fish populations around the world, Dr. Chiba explained that fish numbers are decreasing worldwide due to shrinking habitats for cold-water fish caused by global warming and rising sea temperatures.
Finally, students studied the adverse impacts of environmental damage on humans. They learned what they can do to be more eco-friendly and help prevent marine pollution, including practicing the three R’s (reduce, reuse, recycle) and purchasing ecolabelled products.
About The Floating City and Blue Frontiers
Floating cities are a pioneering sustainability solution whose potential to combat various environmental issues has even seen them discussed by a UN-Habitat roundtable. The rich natural surroundings of this in-game recreation have numerous features designed to help users enjoy learning about sustainability and environmental issues––from the many animals representing endangered species who welcome visitors to the island, to fishing and bug-catching activities that generate a warning when users catch more than they need. The Floating City’s guided learning opportunities even include a museum dedicated to extinct animals and a restaurant with a menu that spotlights disappearing ingredients.
The Floating City was created under the supervision of one co-founder of Blue Frontiers, a company that aims to build an environmentally friendly, sustainable floating island in the near future. Visit https://www.blue-frontiers.com/en/ for more information.
Applying for a special lesson
The Floating City is accepting applications from elementary schools interested in hosting special lessons as described above. If your school would like to participate, please email firstname.lastname@example.org.
Visiting The Floating City
Lie down in your own in-game bed and enter the Dream Address code (DA-8310-5913-5018) to pay a visit to the island.
What you need to visit The Floating City for an in-game guided tour:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- In-game airport access
- Nintendo Switch Online subscription
- Communicative competence in English or Japanese
What you need to visit The Floating City for a non-guided trip:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- Access to in-game dreaming feature
- Nintendo Switch Online subscription
Press office (Material Inc.)
Shinya Honda (+81-70-3874-4264)
Hiroaki Kajiwara (+81-70-3859-5343)
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mawi DNA’s Extractionless Sample Collection Technology Enables BioTech Africa Launch of Affordable COVID-19 Mass Testing Platform25.1.2021 15:00:00 CET | Press release
Mawi DNA Technologies’ iSWAB-Microbiome-EL sample collection technology enables BioTech Africa to implement and launch a new ultra-high throughput COVID-19 testing program. This breakthrough, in conjunction with the ProbeSure™ COVID-19 One Step RT-PCR Kit from 3CR Bioscience, is designed to scale up to a capacity of 200,000 tests per day. “We are extremely proud and humbled to be part of South Africa’s fight against COVID-19 through BioTech Africa’s mass testing efforts,” said Dr. Bassam El-Fahmawi, President and CTO, Mawi DNA Technologies. In addition, Dr. Jenny Leslie, COO of BioTech Africa, worked closely with Scilutions Labware and Hook Diagnostics to identify the best products and supplier partners who could provide reagents to streamline the testing workflow, but also scale to the projected numbers with minimal supply chain disruption. “For the sample collection step, Mawi DNA Technologies’ iSWAB-Microbiome-EL (‘Extractionless’) product was chosen for its multiple benefits. This
AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-225.1.2021 14:13:00 CET | Press release
Today, AchilleS Vaccines, a biotech company based in Siena (Italy), announced the successful industrial development of a novel monoclonal antibody (mAb) to treat COVID-19. The treatment, patented by Prof Rino Rappuoli’s MAD Lab and developed by AchilleS, could greatly improve access to COVID-19 treatment and has several advantages compared to conventional mAbs: it can be administered intramuscularly, avoiding the risks of hospitalization. Additionally, this mAb is highly potent and the low dosage treatment offers significant health and cost benefits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005376/en/ AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2 (Photo: AchilleS Vaccines) The AchilleS antibody project ‘mAbCo19’ will now be further tested in the clinic, possibly leading to an emergency market authorization this summer. AchilleS is developing this new therapeutic in c
“Look for the WELL Health-Safety Seal” Public Awareness Campaign Launches, Featuring Lady Gaga, Jennifer Lopez, Michael B. Jordan, Robert DeNiro, Venus Williams, Wolfgang Puck, Deepak Chopra and 17 th U.S. Surgeon General Richard Carmona25.1.2021 14:00:00 CET | Press release
As the world continues to battle COVID-19 and communities strive to get back to business, it is more important than ever to raise confidence in the safety of buildings and shared spaces. Today, Lady Gaga, Jennifer Lopez, Michael B. Jordan, Robert DeNiro, Venus Williams, Wolfgang Puck, Deepak Chopra and 17th Surgeon General Richard Carmona came together in a new integrated ad campaign to raise awareness about the importance of the WELL Health-Safety Rating, an evidence-based third-party designation to verify that a building or space has taken the necessary steps to prioritize the health and safety of their staff, visitors and other stakeholders. The ambassadors encourage people to look for buildings and spaces with the WELL Health-Safety seal on their windows or doors to feel more confident in their decision to go inside. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005216/en/ WELL Health-Safety Seal (Photo: Business
The Estée Lauder Companies Announces Supply Chain Leadership Updates25.1.2021 14:00:00 CET | Press release
TodayThe Estée Lauder Companies (NYSE:EL) announced that after nearly 13 years with the company, Gregory F. Polcer, Executive Vice President, Global Supply Chain, has made the decision to retire, effective July 1, 2021. He will be succeeded by Roberto Canevari, who will assume the role of Executive Vice President, Global Supply Chain, effective May 1, 2021. Roberto will report directly to Fabrizio Freda, President and Chief Executive Officer. Greg will work closely with Roberto over the next several months to support a smooth and successful transition. “Greg has led ELC’s Global Supply Chain with a great blend of strategic insight and innovative thinking,” said Mr. Freda. “He has evolved our Supply Chain organization into a truly integrated, state-of-the-art global network that touches all aspects of our business and drives tremendous value. He has also been instrumental in elevating and operationalizing our core principles of safety and sustainability, and has been an enthusiastic and
Everbridge Awarded Statewide Vaccine Distribution Deployment Across West Virginia; Everbridge Software Enables Governments, Hospitals and Businesses to Coordinate Rapid Delivery and Communications of COVID-19 Vaccine25.1.2021 13:30:00 CET | Press release
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced COVID-19 Shield™: Vaccine Distribution, an extension to its CEM platform offering risk insights, logistics awareness andvaccine appointment management to support the full spectrum of organizations that develop, manufacture, transport, distribute, regulate, and administer the coronavirus vaccine. The offering also provides governments with a single, unified platform to expedite vaccine coordination, communication and distribution for all residents, including vulnerable populations with special needs. Representing significant adoption for its vaccine distribution software, Everbridge announced the deployment of its CEM Platform to power the digital vaccination distribution system for a variety of municipalities and organizations, including the entire state population of West Virginia, and the County of Sarasota, Florida, among others. This press release features multimedia. View the ful
Velodyne Lidar LIVE! Webinar Series Explores Autonomy in Smarter Cities, Caves, Airports and Disaster Response25.1.2021 13:00:00 CET | Press release
Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a new digital learning series called Velodyne Lidar LIVE! that begins January 28, 2021 at 1:00 p.m. PST. The series kicks off with a conversation featuring Dr. Stefan Hrabar, CEO of Emesent, on how to address autonomous exploration in challenging inaccessible environments such as caves, civil construction works, telecommunications infrastructure and disaster response environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005104/en/ The Velodyne Lidar LIVE! digital learning series examines what’s happening in lidar and mobility to build a safer, more intelligent future. (Graphic: Velodyne Lidar, Inc.) To register for episodes of the free Velodyne Lidar LIVE! webinar series visit: https://velodynelidar.com/events/. Velodyne Lidar LIVE! looks at industry developments regarding the advancement of safer mobility and smarter autonomy. The 45-minute webinars fea
EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT ® (Siltuximab for Injection) in China25.1.2021 13:00:00 CET | Press release
EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) today announced that the Biologics License Application (BLA) for SYLVANT® (siltuximab for injection) was accepted by the China National Medical Products Administration (NMPA) and granted priority review. Siltuximab is a monoclonal antibody approved by the European Medicines Agency (EMA) and Food and Drug Administration (FDA) for the treatment of adult patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative, also known as idiopathic MCD (iMCD). iMCD is a rare, life-threatening and debilitating condition of the lymph nodes and related tissues. Siltuximab is listed in the first batch of New Drugs in Urgent Clinical Need Marketed Overseas by the NMPA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005360/en/ “The BLA acceptance of siltuximab for review, an importan